Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-001724·Medicxi IV LP
Schedule 13G ownership disclosure
RAPT THERAPEUTICS INC
Common Stock, $0.0001 par value · CUSIP: 75382E109
Event date: 2024-12-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Medicxi IV LP
Shares: 21,977,977 · Class: 16.6%
- Medicxi Co-Invest IV LP
Shares: 374,023 · Class: 0.3%
- Medicxi IV GP Limited
Shares: 22,352,000 · Class: 16.9%
- Medicxi Ventures Management (Jersey) Limited
Shares: 22,352,000 · Class: 16.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-001724
- Form type
- SCHEDULE 13G
- Filer
- Medicxi IV LP
- CIK
- CIK 1929290
- Filed
- Jan 06, 2025
- Reporting period
- Dec 27, 2024
- Description
- Schedule 13G beneficial ownership